International Journal of Behavioral Medicine

, Volume 17, Issue 3, pp 223–233 | Cite as

Fibromyalgia Syndrome is Associated with Hypocortisolism

  • Roberto RivaEmail author
  • Paul Jarle Mork
  • Rolf Harald Westgaard
  • Magne Rø
  • Ulf Lundberg



Fibromyalgia syndrome (FMS) is a disease of unknown pathogenesis characterized by chronic musculoskeletal pain. FMS has been also associated with altered endocrinological responses, but findings are inconsistent.


The aim of the present study was to investigate free salivary cortisol levels in FMS patients compared with healthy controls with a particular focus on the cortisol awakening response (CAR). The saliva samples were collected in a controlled hospital-hotel setting, in which the participants’ compliance was high and a number of potential confounders were analyzed.


Twenty-nine chronic female FMS patients and 29 age-matched healthy female controls were recruited. Salivary cortisol samples were investigated eight times: in the afternoon when participants arrived at the hospital, after stress provocation (to be reported separately), in the evening, before they went to sleep, upon awakening, 30 and 60 min later, and during the afternoon of the second day. Questionnaires measuring pain levels, sleeping problems, perceived stress, and personality were administered to the participants. Other psychophysiological measurements were used to assess sleep quality and heart rate.


Patients with FMS had significantly lower cortisol levels during the day, most pronounced in the morning (CAR). The potential confounders analyzed did not influence the results. As expected, FMS patients reported more pain, stress, sleeping problems, anxiety, and depression.


The results lend support to the hypothesis of a dysfunction in the hypothalamus–pituitary–adrenal axis in FMS patients, with generally lower cortisol values, most pronounced upon awakening (CAR).


Chronic musculoskeletal pain Stress Salivary cortisol Psychosomatic symptoms 



This research was supported by grants to Professor Ulf Lundberg from the Swedish Research Council and the Swedish Council for Working Life and Social Research.

Thanks to Associate Professor Petra Lindfors for her suggestions regarding the statistical analysis and for her comments on the preliminary manuscript, Mrs. Ann-Christine Sjöbeck for performing the cortisol assays, Mr. Jens Nilsson for performing the sleep analysis, and to Mr. Håvard Wuttudal Lorås for assisting during data collection.


  1. 1.
    Wolfe F, Smythe HA, Yunus MB, Bennet RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum. 1990;33:160–72.CrossRefPubMedGoogle Scholar
  2. 2.
    Wolfe F, Ross K, Anderson J, Russell I, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 1995;38:19–28.CrossRefPubMedGoogle Scholar
  3. 3.
    Wolfe F, Anderson J, Harkness D, Bennet R, Caro X, Goldenberg D, et al. Prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia. Arthritis Rheum. 1997;40:1560–70.CrossRefPubMedGoogle Scholar
  4. 4.
    Krag N, Norregaard J, Larsen J, Danneskiold-Samsoe BA. Blinded controlled evaluation of anxiety and depressive symptoms in patients with fibromyalgia, as measured by standardized psychometric interview scales. Acta Psychiatr Scand. 1994;89:370–5.CrossRefPubMedGoogle Scholar
  5. 5.
    Catley D, Kaell AT, Kirschbaum C, Stone AA. A naturalistic evaluation of cortisol secretion in persons with fibromyalgia and rheumatoid arthritis. Arthritis Care Res. 2000;13:51–61.CrossRefPubMedGoogle Scholar
  6. 6.
    Crofford LJ, Pillemer SR, Kalogeras KT, Cash JM, Michelson D, Kling MA, et al. Hypothalamic–pituitary–adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum. 1994;37:1583–92.CrossRefPubMedGoogle Scholar
  7. 7.
    Lentjes EG, Griep EN, Boersma JW, Romijn FP, de Kloet ER. Glucocorticoid receptors, fibromyalgia and low back pain. Psychoneuroendocrinology. 1997;22:603–14.CrossRefPubMedGoogle Scholar
  8. 8.
    Klerman EB, Goldenberg DL, Brown EN, Maliszewski AM, Adler GK. Circadian rhythms of women with fibromyalgia. J Clin Endocrinol Metab. 2001;86:1034–9.CrossRefPubMedGoogle Scholar
  9. 9.
    Crofford LJ, Young EA, Engleberg NC, Korszun A, Brucksch CB, McClure LA, et al. Basal circadian and pulsatile ACTH and cortisol secretion in patients with fibromyalgia and/or chronic fatigue syndrome. Brain Behav Immun. 2004;18:314–25.CrossRefPubMedGoogle Scholar
  10. 10.
    Wingenfeld K, Wagner D, Schmidt I, Meinlschmidt G, Hellhammer DH, Heim C. The low-dose dexamethasone suppression test in fibromyalgia. J Psychosom Res. 2007;62:85–91.CrossRefPubMedGoogle Scholar
  11. 11.
    Maes M, Lin A, Bonaccorso S, van Hunsel F, van Gastel A, Delmeire L, et al. Increased 24-hour urinary cortisol excretion in patients with post-traumatic stress disorder and patients with major depression, but not in patients with fibromyalgia. Acta Psychiatr Scand. 1998;98:328–35.CrossRefPubMedGoogle Scholar
  12. 12.
    Adler GK, Kinsley BT, Hurwitz S, Mossey CJ, Goldenberg DL. Reduced hypothalamic–pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome. Am J Med. 1999;106:534–43.CrossRefPubMedGoogle Scholar
  13. 13.
    McLean SA, Williams DA, Harris RE, Kop WJ, Groner KH, Ambrose K, et al. Momentary relationship between cortisol secretion and symptoms in patients with fibromyalgia. Arthritis Rheum. 2005;52:3660–9.CrossRefPubMedGoogle Scholar
  14. 14.
    Macedo J, Hesse J, Turner J, Meyer J, Hellhammer D, Muller C. Glucocorticoid sensitivity in fibromyalgia patients: decreased expression of corticosteroid receptors and glucocorticoid-induced leucine zipper. Psychoneuroendocrinology. 2008;33:799–809.CrossRefPubMedGoogle Scholar
  15. 15.
    Wingenfeld K, Heim C, Schmidt I, Wagner D, Meinlschmidt G, Hellhammer D. HPA axis reactivity and lymphocyte glucocorticoid sensitivity in fibromyalgia syndrome and chronic pelvic pain. Psychosom Med. 2008;70:65–72.CrossRefPubMedGoogle Scholar
  16. 16.
    Griep E, Boersma J, de Kloet E. Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome. J Rheumatol. 1993;20:469–74.PubMedGoogle Scholar
  17. 17.
    Griep EN, Boersma JW, Lentjes EG, Prins AP, van der Korst JK, de Kloet ER. Function of the hypothalamic–pituitary–adrenal axis in patients with fibromyalgia and low back pain. J Rheumatol. 1998;25:1374–81.PubMedGoogle Scholar
  18. 18.
    Loevinger B, Muller D, Alonso C, Coe C. Metabolic syndrome in women with chronic pain. Metabolism. 2007;56:87–93.CrossRefPubMedGoogle Scholar
  19. 19.
    McCain GA, Tilbe KS. Diurnal hormone variation in fibromyalgia syndrome: a comparison with rheumatoid arthritis. J Rheumatol. 1989;16 Suppl 19:154–7.Google Scholar
  20. 20.
    van Denderen J, Boersma J, Zeinstra P, Hollander A, van Neerbos B. Physiological effects of exhaustive physical exercise in primary fibromyalgia syndrome (PFS): is PFS a disorder of neuroendocrine reactivity? Scand J Rheumatol. 1992;21:35–7.CrossRefPubMedGoogle Scholar
  21. 21.
    Calis M, Gokce C, Ates F, Ulker S, Izgi HB, Demir H, et al. Investigation of the hypothalamo-pituitary-adrenal axis (HPA) by 1 microg ACTH test and metyrapone test in patients with primary fibromyalgia syndrome. J Endocrinol Invest. 2004;27:42–6.PubMedGoogle Scholar
  22. 22.
    Gur A, Cevik R, Sarac AJ, Colpan L, Em S. Hypothalamic-pituitary-gonadal axis and cortisol in young women with primary fibromyalgia: the potential roles of depression, fatigue, and sleep disturbance in the occurrence of hypocortisolism. Ann Rheum Dis. 2004;63:1504–6.CrossRefPubMedGoogle Scholar
  23. 23.
    Gur A, Cevik R, Nas K, Colpan L, Sarac S. Cortisol and hypothalamic-pituitary-gonadal axis hormones in follicular-phase women with fibromyalgia and chronic fatigue syndrome and effect of depressive symptoms on the these hormones. Arthritis Res Ther. 2004;6:R232–8.CrossRefPubMedGoogle Scholar
  24. 24.
    Chrousos GP, Gold PW. The concepts of stress and stress system disorders: overview of physical and behavioral homeostasis. JAMA. 1992;267:1244–52.CrossRefPubMedGoogle Scholar
  25. 25.
    Sternberg EM. Hypoimmune fatigue syndromes: diseases of the stress response? J Rheumatol. 1993;20:418–21.PubMedGoogle Scholar
  26. 26.
    Crofford LJ, Demitrack MA. Evidence that abnormalities of central neurohormonal systems are key to understanding fibromyalgia and chronic fatigue syndrome. Rheum Dis Clin N Am. 1996;22:267–84.CrossRefGoogle Scholar
  27. 27.
    Clauw DJ, Chrousos GP. Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuroimmunomodulation. 1997;4:134–53.PubMedGoogle Scholar
  28. 28.
    Fries E, Hesse J, Hellhammer J, Hellhammer DH. A new view on hypocortisolism. Psychoneuroendocrinology. 2005;30:1010–16.CrossRefPubMedGoogle Scholar
  29. 29.
    Heim C, Ehlert U, Hellhammer DH. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology. 2000;25:1–35.CrossRefPubMedGoogle Scholar
  30. 30.
    Weissbecker I, Floyd A, Dedert E, Salmon P, Sephton S. Childhood trauma and diurnal cortisol disruption in fibromyalgia syndrome. Psychoneuroendocrinology. 2006;31:312–24.CrossRefPubMedGoogle Scholar
  31. 31.
    Pruessner J, Wolf O, Hellhammer D, Buske-Kirschbaum A, von Auer K, Jobst S, et al. Free cortisol levels after awakening: a reliable biological marker for the assessment of adrenocortical activity. Life Sci. 1997;61:2539–49.CrossRefPubMedGoogle Scholar
  32. 32.
    Williams E, Magid K, Steptoe A. The impact of time of waking and concurrent subjective stress on the cortisol response to awakening. Psychoneuroendocrinology. 2005;30:139–48.CrossRefPubMedGoogle Scholar
  33. 33.
    Wilhelm I, Born J, Kudielka BM, Schlotz W, Wüst S. Is the cortisol awakening rise a response to awakening? Psychoneuroendocrinology. 2007;32:358–66.CrossRefPubMedGoogle Scholar
  34. 34.
    Kudielka BM, Hellhammer DH, Wüst S. Why do we respond so differently? Reviewing determinants of human salivary cortisol responses to challenge. Psychoneuroendocrinology. 2009;34:2–18.CrossRefPubMedGoogle Scholar
  35. 35.
    Miller GE, Chen E, Zhou ES. If it goes up, must it come down? Chronic stress and the hypothalamic–pituitary–adrenocortical axis in humans. Psychol Bull. 2007;133:25–45.CrossRefPubMedGoogle Scholar
  36. 36.
    Kudielka BM, Bellingrath S, Hellhammer DH. Cortisol in burnout and vital exhaustion: an overview. G Ital Med Lav Ergon [Appl Psychol Work Rehabil Med]. 2006;28:34–42.Google Scholar
  37. 37.
    Boscarino JA. Posttraumatic stress disorder, exposure to combat, and lower plasma cortisol among Vietnam veterans: findings and clinical implications. J Consult Clin Psychol. 1996;64:191–201.CrossRefPubMedGoogle Scholar
  38. 38.
    Wüst S, Wolf J, Hellhammer D, Federenko I, Schommer N, Kirschbaum C. The cortisol awakening response—normal values and confounds. Noise Health. 2000;7:77–85.Google Scholar
  39. 39.
    Clow A, Thorn L, Evans P, Hucklebridge F. The awakening cortisol response: methodological issues and significance. Stress. 2004;7:29–37.CrossRefPubMedGoogle Scholar
  40. 40.
    Federenko I, Wüst S, Hellhammer DH, Dechoux R, Kumsta R, Kirschbaum C. Free cortisol awakening responses are influenced by awakening time. Psychoneuroendocrinology. 2004;29:174–84.CrossRefPubMedGoogle Scholar
  41. 41.
    Borg G, Borg E. A new generation of scaling methods: level anchored ration scaling. Psychologia. 2001;28:15–45.Google Scholar
  42. 42.
    Eriksen H, Ihlebæk C, Ursin H. A scoring system for Subjective Health Complaints (SHC). Scand J Public Health. 1999;27:63–72.CrossRefPubMedGoogle Scholar
  43. 43.
    Schalling D, Edman G. Personality and vulnerability to psychopathology: the development of the Karolinska Scales of Personality (KSP). Stockholm: Karolinska Institutet; 1987.Google Scholar
  44. 44.
    Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24:385–96.CrossRefPubMedGoogle Scholar
  45. 45.
    Eysenck H, Eysenck S. The manual for the Eysenck Personality Questionnaire. London: Hodder & Stoughton; 1975.Google Scholar
  46. 46.
    Iber C, Ancoli-Israel S, Chesson A, Quan SF. The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications. 1st ed. Westchester: American Academy of Sleep Medicine; 2007.Google Scholar
  47. 47.
    Pruessner J, Kirschbaum C, Meinlschmid G, Hellhammer D. Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology. 2003;28:916–31.CrossRefPubMedGoogle Scholar
  48. 48.
    Pruessner JC, Hellhammer DH, Kirschbaum C. Burnout, perceived stress, and cortisol responses to awakening. Psychosom Med. 1999;61:197–204.PubMedGoogle Scholar
  49. 49.
    Roberts AD, Wessely S, Chalder T, Papadopoulos A, Cleare AJ. Salivary cortisol response to awakening in chronic fatigue syndrome. Br J Psychiatry. 2004;184:136–41.CrossRefPubMedGoogle Scholar
  50. 50.
    Rohleder N, Joksimovic L, Wolf JM, Kirschbaum C. Hypocortisolism and increased glucocorticoid sensitivity of proinflammatory cytokine production in Bosnian war refugees with posttraumatic stress disorder. Biol Psychiatry. 2004;55:745–51.CrossRefPubMedGoogle Scholar
  51. 51.
    Buchanan TW, Kern S, Allen JS, Tranel D, Kirschbaum C. Circadian regulation of cortisol after hippocampal damage in humans. Biol Psychiatry. 2004;56:651–6.CrossRefPubMedGoogle Scholar
  52. 52.
    Wolf OT, Fujiwara E, Luwinski G, Kirschbaum C, Markowitsch HJ. No morning cortisol response in patients with severe global amnesia. Psychoneuroendocrinology. 2005;30:101–5.CrossRefPubMedGoogle Scholar
  53. 53.
    Hellhammer J, Fries E, Schweisthal OW, Schlotz W, Stone AA, Hagemann D. Several daily measurements are necessary to reliably assess the cortisol rise after awakening: State- and trait components. Psychoneuroendocrinology. 2007;32:80–6.CrossRefPubMedGoogle Scholar
  54. 54.
    Chida Y, Steptoe A. Cortisol awakening response and psychosocial factors: a systematic review and meta-analysis. Biol Psychol. 2009;80:265–78.CrossRefPubMedGoogle Scholar
  55. 55.
    Van Houdenhove B, Van Den Eede F, Luyten P. Does hypothalamic-pituitary-adrenal axis hypofunction in chronic fatigue syndrome reflect a ‘crash’ in the stress system? Med hypothesis. 2009;72:701–5.CrossRefGoogle Scholar
  56. 56.
    McEwen BS. Protective and damaging effects of stress mediators. N Engl J Med. 1998;338:171–9.CrossRefPubMedGoogle Scholar
  57. 57.
    Glass JM, Lyden AK, Petzke F, Stein P, Whalen G, Ambrose K, et al. The effect of brief exercise cessation on pain, fatigue, and mood symptom development in healthy, fit individuals. J Psychosom Res. 2004;57:391–8.PubMedGoogle Scholar
  58. 58.
    Shaver JL, Lentz M, Landis CA, Heitkemper MM, Buchwald DS, Woods NF. Sleep, psychological distress, and stress arousal in women with fibromyalgia. Res Nurs Health. 1997;20:247–57.CrossRefPubMedGoogle Scholar
  59. 59.
    Ekstedt M, Åkerstedt T, Söderström M. Microarousals during sleep are associated with increased levels of lipids, cortisol, and blood pressure. Psychosom Med. 2004;66:925–31.CrossRefPubMedGoogle Scholar
  60. 60.
    Vgontzas AN, Bixler EO, Lin HM, Prolo P, Mastorakos G, Vela-Bueno A, et al. Chronic insomnia is associated with nyctohemeral activation of thehypothalamic–pituitary–adrenal axis: clinical implications. J Clin Endocrinol Metab. 2001;86:3787–94.CrossRefPubMedGoogle Scholar
  61. 61.
    Shaver J, Johnston S, Lentz M, Landis C. Stress exposure, psychological distress, and physiological stress activation in midlife women with insomnia. Psychosom Med. 2002;64:793–802.CrossRefPubMedGoogle Scholar
  62. 62.
    Backhaus J, Junghanns K, Hohagen F. Sleep disturbances are correlated with decreased morning awakening salivary cortisol. Psychoneuroendocrinology. 2004;29:1184–91.CrossRefPubMedGoogle Scholar
  63. 63.
    Vgontzas A, Mastorakos G, Bixler E, Kales A, Gold P, Chrousos GP. Sleep deprivation effects on the activity of the hypothalamic-pituitary-adrenal and growth axes: potential clinical implications. Clin Endocrinol (Oxf). 1999;51:205–15.CrossRefGoogle Scholar
  64. 64.
    Leproult R, Copinschi G, Buxton O, Van Cauter E. Sleep loss results in an elevation of cortisol levels the next evening. Sleep. 1997;20:865–70.PubMedGoogle Scholar
  65. 65.
    Pasquali R, Vicennati V. The abdominal obesity phenotype and insulin resistance are associated with abnormalities of the hypothalamic-pituitaryadrenal axis in humans. Horm Metab Res. 2000;32:521–5.CrossRefPubMedGoogle Scholar
  66. 66.
    Wallerius S, Rosmond R, Ljung T, Holm G, Bjorntorp P. Rise in morning saliva cortisol is associated with abdominal obesity in men: a preliminary report. J Endocrinol Invest. 2003;26:616–19.PubMedGoogle Scholar
  67. 67.
    Steptoe A, Kunz-Ebrecht SR, Brydon L, Wardle J. Central adiposity and cortisol responses to waking in middle-aged men and women. Int J Obes. 2004;28:1168–73.CrossRefGoogle Scholar
  68. 68.
    Alen M, Pakarinen A, Häikkinen K, Komi P. Responses of serum androgenic-anabolic and catabolic hormones to prolonged strength training. Int J Sports Med. 1988;9:229–33.CrossRefPubMedGoogle Scholar
  69. 69.
    Tabata I, Atomi Y, Mutoh Y, Miyashita M. Effect of physical training on responses of serum adrenocorticotropic hormone during prolonged exhausting exercise. Eur J Appl Physiol. 1990;61:188–92.CrossRefGoogle Scholar
  70. 70.
    O’Connor P, Morgan W, Raglin J, Barksdale C, Kalin N. Mood state and salivary cortisol levels following overtraining in female swimmers. Psychoneuroendocrinology. 1989;14(4):303–10.CrossRefPubMedGoogle Scholar
  71. 71.
    Filaire E, Duché P, Lac G, Robert A. Saliva cortisol, physical exercise and training: influences of swimming and handball on cortisol concentrations in women. Eur J Appl Physiol. 1996;74:274–8.CrossRefGoogle Scholar
  72. 72.
    Bouget M, Rouveix M, Michaux O, Pequignot J, Filaire E. Relationships among training stress, mood and dehydroepiandrosterone sulphate/cortisol ratio in female cyclists. J Sports Sci. 2006;24(12):1297–302.CrossRefPubMedGoogle Scholar
  73. 73.
    Kudielka BM, Broderick JE, Kirschbaum C. Compliance with saliva sampling protocols: electronic monitoring reveals invalid cortisol daytime profiles in noncompliant subjects. Psychosom Med. 2003;65:313–19.CrossRefPubMedGoogle Scholar
  74. 74.
    Kudielka B, Kirschbaum C. Awakening cortisol responses are influenced by health status and awaking time but not by menstrual phase. Psychoneuroendocrinology. 2003;28:35–47.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Behavioral Medicine 2010

Authors and Affiliations

  • Roberto Riva
    • 1
    Email author
  • Paul Jarle Mork
    • 2
  • Rolf Harald Westgaard
    • 3
  • Magne Rø
    • 4
  • Ulf Lundberg
    • 5
    • 6
  1. 1.Department of PsychologyStockholm UniversityStockholmSweden
  2. 2.Human Movement Science Programme, Norwegian University of Science and TechnologyTrondheimNorway
  3. 3.Department of Industrial Economics and Technology ManagementNorwegian University of Science and TechnologyTrondheimNorway
  4. 4.Department of NeuroscienceNorwegian University of Science and TechnologyTrondheimNorway
  5. 5.Department of PsychologyStockholm UniversityStockholmSweden
  6. 6.CHESS (Centre for Health Equity Studies)Stockholm UniversityStockholmSweden

Personalised recommendations